Development of new therapy for canine mammary cancer with recombinant measles virus

Oncolytic virotherapy is a promising treatment strategy for cancer. We previously generated a recombinant measles virus (rMV-SLAMblind) that selectively uses a poliovirus receptor-related 4 (PVRL4/Nectin4) receptor, but not signaling lymphocyte activation molecule (SLAM). We demonstrated that the vi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Ther Oncolytics
Главные авторы: Shoji, Koichiro, Yoneda, Misako, Fujiyuki, Tomoko, Amagai, Yosuke, Tanaka, Akane, Matsuda, Akira, Ogihara, Kikumi, Naya, Yuko, Ikeda, Fusako, Matsuda, Hiroshi, Sato, Hiroki, Kai, Chieko
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782952/
https://ncbi.nlm.nih.gov/pubmed/27119113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.22
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы